917200

Leading Pharma, LLC — FEI 3001611969

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 6, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Fairfield, NJ (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)